Palisade Bio Quote - PALI

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

1.32

Bid

1.31

Ask

1.33

Volume

559

0.00 Day's Range 0.00

1.25 52 Week Range 9.09

Market Cap

1.755M

Previous Close

1.33

Open

Last Trade

1.32

Last Trade Time

05:27:03

Financial Volume

VWAP

Average Volume (3m)

1,718,267

Shares Outstanding

1,329,516

Dividend Yield

PE Ratio

-0.18

Earnings Per Share (EPS)

-9.25

Revenue

250k

Net Profit

-12.3M

Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor wi... Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.palisadebio.com.

Headquarters

Camden, Delaware, USA

Founded

Palisade Bio Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker PALI. The last closing price for Palisade Bio was US$1.33. Over the last year, Palisade Bio shares have traded in a share price range of US$ 1.25 to US$ 9.09.

Palisade Bio currently has 1,329,516 shares outstanding. The market capitalization of Palisade Bio is US$1.77 million. Palisade Bio has a price to earnings ratio (PE ratio) of -0.18.

Palisade Bio Selected for Poster Presentation at the 2025 Crohn’s & Colitis Congress

Carlsbad, CA, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company focused on...

Palisade Bio to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar

Live webcast on Wednesday, January 29th at 2:20 PM ET Carlsbad, CA, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a...

Palisade Bio Completes All Five SAD Cohorts and Advances to MAD Cohorts of Phase 1a/b Study of PALI-2108 for Treatment of Ulcerative Colitis

Company on track to report topline data in first half of 2025 Positive preliminary data from all five single ascending dose (SAD) cohorts ranging from 15mg to 450mg support safety and...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.17	-11.4093959732	1.49	1.4995	1.25	113417	1.35509491	CS
4	-0.65	-32.9949238579	1.97	2.0153	1.25	918052	1.63256515	CS
12	-0.93	-41.3333333333	2.25	3.3	1.25	1718267	2.18829217	CS
26	-2.22	-62.7118644068	3.54	4.318	1.25	781631	2.23304401	CS
52	-6.18	-82.4	7.5	9.09	1.25	698342	3.924636	CS
156	-688.68	-99.8086956522	690	1147.5	1.25	1973913	105.98102318	CS
260	-6748.68	-99.9804444444	6750	8182.5	1.25	1734080	324.84101868	CS

PALI - Frequently Asked Questions (FAQ)

What is the current Palisade Bio share price?

The current share price of Palisade Bio is US$ 1.32

How many Palisade Bio shares are in issue?

Palisade Bio has 1,329,516 shares in issue

What is the market cap of Palisade Bio?

The market capitalisation of Palisade Bio is USD 1.77M

What is the 1 year trading range for Palisade Bio share price?

Palisade Bio has traded in the range of US$ 1.25 to US$ 9.09 during the past year

What is the PE ratio of Palisade Bio?

The price to earnings ratio of Palisade Bio is -0.18

What is the cash to sales ratio of Palisade Bio?

The cash to sales ratio of Palisade Bio is 8.83

What is the reporting currency for Palisade Bio?

Palisade Bio reports financial results in USD

What is the latest annual turnover for Palisade Bio?

The latest annual turnover of Palisade Bio is USD 250k

What is the latest annual profit for Palisade Bio?

The latest annual profit of Palisade Bio is USD -12.3M

What is the registered address of Palisade Bio?

The registered address for Palisade Bio is 2140 S DUPONT HWY, CAMDEN, DELAWARE, 19934

What is the Palisade Bio website address?

The website address for Palisade Bio is www.palisadebio.com.

Which industry sector does Palisade Bio operate in?

Palisade Bio operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
EDRYEuroDry Ltd	US$ 17.07 (62.57%)	6
FACTFACT II Acquisition Corporation	US$ 15.82 (58.99%)	49
CCECCapital Clean Energy Carriers Corporation	US$ 30.40 (58.83%)	120
UTSIUTStarcom Holdings Corporation	US$ 4.11 (58.69%)	220
FSEAFirst Seacoast Bancorp Inc	US$ 16.50 (58.35%)	8
PBBKPB Bankshares Inc	US$ 10.02 (-33.55%)	10
OPBKOP Bancorp	US$ 10.02 (-32.30%)	6
AVGRAvinger Inc	US$ 0.38 (-32.13%)	77.89k
KTTAPasithea Therapeutics Corporation	US$ 1.905 (-30.47%)	104.9k
FORMFormFactor Inc	US$ 29.01 (-29.45%)	23.37k
CYNCYNGN Inc	US$ 0.0904 (10.24%)	19.82M
DGLYDigital Ally Inc	US$ 0.21 (-0.94%)	11.36M
RIMEAlgorhythm Holdings Inc	US$ 0.0209 (0.00%)	9.42M
RXRXRecursion Pharmaceuticals Inc	US$ 8.61 (8.71%)	7.39M
RANIRani Therapeutics Holdings Inc	US$ 1.63 (13.19%)	6.76M